GILD vs TTI · P/E 18, rev $29.44B vs P/E 170, $1.50B cap
Gilead Sciences Inc (GILD) versus Tetra Technologies Inc (TTI) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Tetra Technologies Inc (TTI) is a conglomerates company listed on NYSE.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
TTI does not have a complete income-statement cache yet.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. TTI currently screens at market cap $1.50B and trailing P/E 169.5.
Not investment advice. Open the GILD and TTI stock pages for the full models.
Not investment advice.